Skip to main content
. 2024 Nov 6;16(22):3752. doi: 10.3390/cancers16223752
BC breast cancer
OR odds ratio
CI confidence interval
HR trastuzumab resistant
HDAC6 histone deacetylase 6
HDAC6i histone deacetylase 6 inhibitors
HSP90 heat shock protein 90
IHC immunohistochemistry
FISH fluorescence in situ hybridization
ER estrogen receptor
FFPE formalin-fixed paraffin-embedded
FOV field of view
TIS tumor inflammation signature
ROR risk of recurrence
OD optical density
PPI Protein–protein interaction
GO gene ontology
MCODE molecular complex detection
OS overall survival
SD standard deviation
FDR false discovery rate
ROC receiver operating characteristics curve
DFS disease-free survival
WT wild type